Study finds new clues in understanding relapse in breast cancer

    Source: Xinhua| 2018-09-06 06:52:33|Editor: Yamei
    Video PlayerClose

    CHICAGO, Sept. 5 (Xinhua) -- A genomic analysis has linked certain DNA mutations to a high risk of relapse in estrogen receptor positive breast cancer, while other mutations were associated with better outcomes, according to U.S. researchers.

    The researchers at Washington University School of Medicine in St. Louis, the Baylor College of Medicine and the University of British Columbia analyzed tumor samples from more than 2,500 patients with estrogen receptor positive breast cancer, one of the most common forms of the disease.

    They found that although mutations in DDR1 and NF1 are rare, they are associated with early relapse, which makes them much more common in patients who unfortunately die from the disease.

    One unique element of the study was the age of the samples. Many were over 20 years old, allowing the researchers to know the full history of how the patients fared.

    The study also confirmed past work showing that relatively common mutations in genes called MAP3K1 and TP53 had opposite effects on tumor aggressiveness. Patients with MAP3K1 mutations did well, while those with TP53 mutations were likely to have a recurrence.

    The study has identified three genes, namely DDR1, PIK3R1 and NF1, with relatively uncommon mutations that were associated with cancer recurrence and spreading.

    "We would like to help doctors identify patients who are likely to do well versus those who are likely to have a recurrence," said first author Obi L. Griffith, an assistant professor of medicine and an assistant director of the McDonnell Genome Institute at Washington University School of Medicine.

    "Those with mutations that are associated with a good prognosis may need less intensive therapy than they might otherwise receive. But if a patient's tumor has mutations linked to high risk of relapse, it's useful to know that early so they can be treated with more aggressive therapies or even potential investigational therapies that could be targeted to their specific mutations," Griffith added.

    The researchers also pointed out the importance of continuing to sequence cancer genomes.

    More than 266,000 women in the United States are diagnosed with invasive breast cancer each year, according to the American Cancer Society, and about 70 percent of cases are estrogen receptor positive.

    The study was published on Tuesday in the journal Nature Communications.

    TOP STORIES
    EDITOR’S CHOICE
    MOST VIEWED
    EXPLORE XINHUANET
    010020070750000000000000011103261374478871
    主站蜘蛛池模板: 狠狠做五月深爱婷婷天天综合| 国产中文在线观看| 国产亚洲美女精品久久久久 | 欧美人与动另类在线| 男人添女人下部高潮全视频| 91理论片午午伦夜理片久久| 一级特级aaaa毛片免费观看| 亚洲成av人片在线观看| 免费一级欧美大片视频在线 | 国产720刺激在线视频| 婷婷五月综合激情| 思思99re66在线精品免费观看| 性欧美视频在线观看| 成人在线观看国产| 性欧美18-19性猛交| 日本三级很黄试看120秒| 精品人成电影在线观看| 精精国产XXXX视频在线| 69国产成人精品午夜福中文 | 真精华布衣3d1234正版图2020/015 | 2018中文字幕在线观看| 一边摸一边爽一边叫床免费视频| 久久久久99精品成人片欧美| 一个人看的片免费高清大全| japanesehd熟女熟妇| 一级艳片加勒比女海盗1| 中文字幕在线视频网站| 丰满饥渴老女人hd| 久久不射电影院| 四虎成年永久免费网站| 国产亚洲美女精品久久久| 国产精品麻豆高清在线观看| 最近的中文字幕视频完整| 欧美日韩一区二区三区四区在线观看| 精品一区二区三区自拍图片区 | 久久国产高潮流白浆免费观看| 国产精品免费视频网站| 护士的护士服被扒了下来小说| 成人小视频在线观看免费| 国内揄拍国内精品视频| 国产综合久久久久久鬼色|